| # | Pathway | Proteins |
|---|
| 1 | Vitamin digestion and absorption | ENSAPLP00000011529, ENSAPLP00000003561, ENSAPLP00000002020, ENSAPLP00000016339 |
| 2 | Fat digestion and absorption | ENSAPLP00000011529, ENSAPLP00000003561, ENSAPLP00000002020, ENSAPLP00000016339 |
| 3 | African trypanosomiasis | ENSAPLP00000016307, ENSAPLP00000011291, ENSAPLP00000002020 |
| 4 | Protein digestion and absorption | ENSAPLP00000011483, ENSAPLP00000008210, ENSAPLP00000012993, ENSAPLP00000012763 |
| 5 | Amoebiasis | ENSAPLP00000012216, ENSAPLP00000011483, ENSAPLP00000011291, ENSAPLP00000004050, ENSAPLP00000002160 |
| 6 | Complement and coagulation cascades | ENSAPLP00000010484, ENSAPLP00000004158, ENSAPLP00000003063, ENSAPLP00000015167 |
| 7 | Arginine and proline metabolism | ENSAPLP00000008767, ENSAPLP00000002913, ENSAPLP00000010692 |
| 8 | Proteoglycans in cancer | ENSAPLP00000011483, ENSAPLP00000013972, ENSAPLP00000013787, ENSAPLP00000013831, ENSAPLP00000013792, ENSAPLP00000003495 |
| 9 | Salmonella infection | ENSAPLP00000009727, ENSAPLP00000005955, ENSAPLP00000003495 |
| 10 | TGF-beta signaling pathway | ENSAPLP00000012513, ENSAPLP00000013831 |
| 11 | Estrogen signaling pathway | ENSAPLP00000000447, ENSAPLP00000013972, ENSAPLP00000014548 |
| 12 | Systemic lupus erythematosus | ENSAPLP00000011291, ENSAPLP00000002160, ENSAPLP00000015167 |
| 13 | Leishmaniasis | ENSAPLP00000011291, ENSAPLP00000015167 |
| 14 | Tight junction | ENSAPLP00000012466, ENSAPLP00000005955, ENSAPLP00000002160, ENSAPLP00000003495 |
| 15 | MAPK signaling pathway | ENSAPLP00000000447, ENSAPLP00000002674, ENSAPLP00000004050, ENSAPLP00000003495 |
| 16 | Staphylococcus aureus infection | ENSAPLP00000011291, ENSAPLP00000015167 |
| 17 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | ENSAPLP00000012522, ENSAPLP00000002674, ENSAPLP00000002160 |
| 18 | Legionellosis | ENSAPLP00000000447, ENSAPLP00000015167 |
| 19 | VEGF signaling pathway | ENSAPLP00000004050, ENSAPLP00000003495 |
| 20 | Dilated cardiomyopathy | ENSAPLP00000012522, ENSAPLP00000011291, ENSAPLP00000002674 |
| 21 | Endocytosis | ENSAPLP00000000447, ENSAPLP00000000706, ENSAPLP00000003542, ENSAPLP00000016193, ENSAPLP00000008982, ENSAPLP00000003495 |
| 22 | Regulation of actin cytoskeleton | ENSAPLP00000009727, ENSAPLP00000005411, ENSAPLP00000005955, ENSAPLP00000002160, ENSAPLP00000003495 |
| 23 | Asthma | ENSAPLP00000011291 |
| 24 | Transcriptional misregulation in cancer | ENSAPLP00000011291, ENSAPLP00000013972 |
| 25 | Thyroid hormone synthesis | ENSAPLP00000001822, ENSAPLP00000014548 |
| 26 | Focal adhesion | ENSAPLP00000011483, ENSAPLP00000013787, ENSAPLP00000005411, ENSAPLP00000002160, ENSAPLP00000003495 |
| 27 | Epstein-Barr virus infection | ENSAPLP00000000447, ENSAPLP00000011291, ENSAPLP00000010003, ENSAPLP00000004050 |
| 28 | Measles | ENSAPLP00000000447, ENSAPLP00000011291 |
| 29 | PPAR signaling pathway | ENSAPLP00000006229, ENSAPLP00000002020 |
| 30 | Citrate cycle (TCA cycle) | ENSAPLP00000003725, ENSAPLP00000008955 |
| 31 | Bacterial invasion of epithelial cells | ENSAPLP00000000706, ENSAPLP00000015963, ENSAPLP00000003495 |
| 32 | Allograft rejection | ENSAPLP00000011291 |
| 33 | Leukocyte transendothelial migration | ENSAPLP00000013972, ENSAPLP00000002160, ENSAPLP00000003495 |
| 34 | Intestinal immune network for IgA production | ENSAPLP00000011291 |
| 35 | Primary immunodeficiency | ENSAPLP00000011291 |
| 36 | Autoimmune thyroid disease | ENSAPLP00000011291 |
| 37 | Shigellosis | ENSAPLP00000009727, ENSAPLP00000003495 |
| 38 | Histidine metabolism (no map in kegg database) | ENSAPLP00000008767 |
| 39 | Glycerolipid metabolism | ENSAPLP00000005894 |
| 40 | Renin-angiotensin system | ENSAPLP00000012763 |
| 41 | PI3K-Akt signaling pathway | ENSAPLP00000011483, ENSAPLP00000011291, ENSAPLP00000013787, ENSAPLP00000014548 |
| 42 | Malaria | ENSAPLP00000016307 |
| 43 | Bladder cancer | ENSAPLP00000013972 |
| 44 | Fc gamma R-mediated phagocytosis | ENSAPLP00000011291, ENSAPLP00000003495 |
| 45 | Vascular smooth muscle contraction | ENSAPLP00000005411, ENSAPLP00000005955 |
| 46 | NOD-like receptor signaling pathway | ENSAPLP00000014548 |
| 47 | Pentose and glucuronate interconversions | ENSAPLP00000005894 |
| 48 | Adherens junction | ENSAPLP00000002160, ENSAPLP00000003495 |
| 49 | Viral carcinogenesis | ENSAPLP00000002160, ENSAPLP00000003495, ENSAPLP00000015167 |
| 50 | Mineral absorption | ENSAPLP00000009906 |
| 51 | 2-Oxocarboxylic acid metabolism (no map in kegg database) | ENSAPLP00000003725 |
| 52 | Hypertrophic cardiomyopathy (HCM) | ENSAPLP00000012522, ENSAPLP00000002674 |
| 53 | Calcium signaling pathway | ENSAPLP00000011291, ENSAPLP00000005411 |
| 54 | Hematopoietic cell lineage | ENSAPLP00000011291 |
| 55 | Tuberculosis | ENSAPLP00000011291, ENSAPLP00000015167 |
| 56 | ECM-receptor interaction | ENSAPLP00000011483, ENSAPLP00000013787 |
| 57 | Arachidonic acid metabolism | ENSAPLP00000001822 |
| 58 | Galactose metabolism | ENSAPLP00000005894 |
| 59 | Fructose and mannose metabolism | ENSAPLP00000005894 |
| 60 | Oxytocin signaling pathway | ENSAPLP00000005411, ENSAPLP00000002674 |
| 61 | Herpes simplex infection | ENSAPLP00000014318, ENSAPLP00000015167 |
| 62 | NF-kappa B signaling pathway | ENSAPLP00000011291 |
| 63 | beta-Alanine metabolism (no map in kegg database) | ENSAPLP00000008767 |
| 64 | Pancreatic cancer | ENSAPLP00000003495 |
| 65 | Rheumatoid arthritis | ENSAPLP00000011291 |
| 66 | MicroRNAs in cancer | ENSAPLP00000013972, ENSAPLP00000010003 |
| 67 | Lysine degradation | ENSAPLP00000008955 |
| 68 | GABAergic synapse (no map in kegg database) | ENSAPLP00000003730 |
| 69 | Amyotrophic lateral sclerosis (ALS) (no map in kegg database) | ENSAPLP00000001822 |
| 70 | Pertussis | ENSAPLP00000015167 |
| 71 | Endocrine and other factor-regulated calcium reabsorption | ENSAPLP00000000706 |
| 72 | B cell receptor signaling pathway | ENSAPLP00000011291 |
| 73 | Platelet activation | ENSAPLP00000011483, ENSAPLP00000005411 |
| 74 | TNF signaling pathway | ENSAPLP00000013972 |
| 75 | Natural killer cell mediated cytotoxicity | ENSAPLP00000011291 |
| 76 | Renal cell carcinoma | ENSAPLP00000003495 |
| 77 | Prostate cancer | ENSAPLP00000014548 |
| 78 | Glyoxylate and dicarboxylate metabolism | ENSAPLP00000003725 |
| 79 | Glutathione metabolism | ENSAPLP00000001822 |
| 80 | Fc epsilon RI signaling pathway | ENSAPLP00000011291 |
| 81 | Viral myocarditis | ENSAPLP00000011291 |
| 82 | Synaptic vesicle cycle | ENSAPLP00000000706 |
| 83 | T cell receptor signaling pathway | ENSAPLP00000003495 |
| 84 | Cardiac muscle contraction | ENSAPLP00000002674 |
| 85 | Antigen processing and presentation | ENSAPLP00000000447 |
| 86 | Rap1 signaling pathway | ENSAPLP00000009727, ENSAPLP00000003495 |
| 87 | Gastric acid secretion | ENSAPLP00000005411 |
| 88 | Lysosome | ENSAPLP00000014136, ENSAPLP00000000706 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection | ENSAPLP00000003495 |
| 90 | Prion diseases (no map in kegg database) | ENSAPLP00000000447 |
| 91 | Phagosome | ENSAPLP00000011291, ENSAPLP00000015167 |
| 92 | GnRH signaling pathway | ENSAPLP00000003495 |
| 93 | Chagas disease (American trypanosomiasis) | ENSAPLP00000015167 |
| 94 | RNA degradation | ENSAPLP00000006939 |
| 95 | Protein processing in endoplasmic reticulum | ENSAPLP00000000447, ENSAPLP00000014548 |
| 96 | Phospholipase D signaling pathway | ENSAPLP00000011291 |
| 97 | Spliceosome | ENSAPLP00000014318, ENSAPLP00000000447 |
| 98 | Hepatitis B | ENSAPLP00000013972 |
| 99 | Toxoplasmosis | ENSAPLP00000000447 |
| 100 | Pathways in cancer | ENSAPLP00000013972, ENSAPLP00000014548, ENSAPLP00000003495 |
| 101 | Neurotrophin signaling pathway | ENSAPLP00000003495 |
| 102 | Influenza A | ENSAPLP00000000447 |
| 103 | Pathogenic Escherichia coli infection | ENSAPLP00000003495 |
| 104 | Carbon metabolism (no map in kegg database) | ENSAPLP00000003725, ENSAPLP00000008955 |
| 105 | Axon guidance | ENSAPLP00000003495 |
| 106 | Huntington's disease | ENSAPLP00000000706, ENSAPLP00000001822 |
| 107 | cGMP-PKG signaling pathway | ENSAPLP00000005411 |
| 108 | Adrenergic signaling in cardiomyocytes | ENSAPLP00000002674 |
| 109 | Biosynthesis of amino acids (no map in kegg database) | ENSAPLP00000003725 |
| 110 | Non-alcoholic fatty liver disease (NAFLD) | ENSAPLP00000003495 |
| 111 | Ras signaling pathway | ENSAPLP00000003495 |
| 112 | Chemokine signaling pathway | ENSAPLP00000003495 |
| 113 | Parkinson's disease | ENSAPLP00000006744 |
| 114 | RNA transport | ENSAPLP00000006444 |
| 115 | Metabolic pathways (no map in kegg database) | ENSAPLP00000008767, ENSAPLP00000002913, ENSAPLP00000005894, ENSAPLP00000003725, ENSAPLP00000008955, ENSAPLP00000010692 |